empty Federal Aviation Administration Seal
empty FAA Home About FAA Jobs News Library empty
empty Pilots Travelers Mechanics More empty
empty
empty
empty
empty
Aircraft
empty
Airports &
Air Traffic
empty
Data &
Statistics
empty
Education &
Research
empty
Licenses &
Certificates
empty
Regulations &
Policies
empty
Safety
empty
Search:  

AME Assisted - All Classes
Hyperthyroidism

Note:
  • The Examiner may issue an airman medical certificate if the applicant is euthyroid, stable, and does not have other organ system involvement. See Item 48., General Systemic, Aerospace Medical Disposition.
  • The Examiner must document the period of stability, laboratory evidence of euthyroid state and absence of other organ system
    in Item 60 of the FAA Form 8500-8.
If Applicant does not meet the above criteria, the Examiner must follow the AASI process.

AME Assisted Special Issuance (AASI) is a process that provides Examiners the ability to re-issue an airman medical certificate under the provisions of an Authorization for Special Issuance of a Medical Certificate (Authorization) to an applicant who has a medical condition that is disqualifying under Title 14 of the Code of Federal Regulations
(14 CFR) part 67.

An FAA physician provides the initial certification decision and grants the Authorization in accordance with 14 CFR ยง 67.401. The Authorization letter is accompanied by attachments that specify the information that treating physician(s) must provide for the re-issuance determination. If this is a first time issuance of an Authorization for the above disease/condition, and the applicant has all of the requisite medical information necessary for a determination, the Examiner must defer and submit all of the documentation to the AMCD or RFS for the initial determination.

Examiners may re-issue an airman medical certificate under the provisions of an Authorization, if the applicant provides the following:
  • An Authorization granted by the FAA current statement of the condition since last FAA medical examination;
  • The name and dosage of medication(s) used for treatment and/or prevention with comment regarding side effects; and
  • Current thyroid function studies performed within last 90 days.
The Examiner must defer to the AMCD or Region if:
  • The thyroid function studies are elevated, suggesting inadequate treatment; or
  • The applicant developed an associated illness, such as dysrhythmia.

Updated: 12:08 pm ET August 31, 2006

empty empty empty
empty USA.gov | Privacy Policy | Web Policies & Notices | Site Map | Contact FAA | Frequently Asked Questions | Forms empty
empty Department of Transportation Seal U.S. Department of Transportation
Federal Aviation Administration
800 Independence Avenue, SW
Washington, DC 20591
1-866-TELL-FAA (1-866-835-5322)
empty
empty Readers & Viewers: PDF Reader | MS Word Viewer | MS PowerPoint Viewer | MS Excel Viewer | Zip
empty